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1. Introduction 2. Materials and methods 
Triglyceride moieties of circulating chylomicrons 
and very low density lipoproteins (VLDL) are natural 
substrates for lipoprotein lipase (LPL) (EC 3.1 .1.34), 
an enzyme functional at the vascular endothelial sur- 
face [ 1,2]. A synthetic substrate, triolein emulsified 
in glycerol [3], has gained widespread use. We had 
employed this latter substrate to compare heparin- 
releasable LPL with the remaining, non-releasable 
LPL in the perfused rat heart [4]. The 2 fractions 
(releasable and non-releasable LPL) displayed a major 
difference in their app. Km-values. We associated the 
high affinity nature of the ‘releasable’ fraction with 
the functional, endothelial-bound lipase. The low 
affinity nature of the ‘non-releasable’ fraction was 
compatible with its presumed role as precursor of the 
functional lipase and its suggested location in the 
parenchymal cells of the tissue [ 1,5,6]. 
Male Sprague-Dawley rats (Hilltop Lab), 200- 
300 g, were fasted overnight. The preparation of the 
lipase fractions from perfusate and residual heart tis- 
sue has been described [4]. The natural substrate used 
was chyle, collected from the thoracic duct of rats 
pre-fed with 1-2 ml evaporated milk containing 
100 PCi [ 1 -14C] palmitate (Rose Chemical Co.). More 
than 96% of the radioactivity was incorporated into 
the chylomicron fraction as revealed by isolation of 
the latter by centrifugation at 30 000 X g for 45 min 
at 16’C [ll]. The triglyceride content was deter- 
mined enzymatically [ 121. Synthetic substrate was 
prepared by emulsifying triolein in glycerol with leci- 
thin as detergent [3,4]. 
In [7], LPL activity within isolated heart cells 
could not be demonstrated using a natural substrate, 
VLDL. These findings were in contrast to [8-IO] 
where synthetic substrates were employed and in 
which substantial LEL activity was detected within 
the cells. Thus, we have employed a natural substrate, 
chylomicrons present in chyle, to determine: 
(i) If indeed the non-releasable fraction in the per- 
fused heart is capable of hydrolyzing chylomi- 
cron triglyceride; 
For the lipase reaction, 100 /..d of the substrate 
emulsion was added to 100 ~1 of the enzyme fraction, 
containing either releasable or non-releasable LPL 
pre-purified by heparin-Sepharose chromatography 
[4]. One milliunit (mu) of enzyme activity represents 
1 nmol free fatty acid released/min. For Km determi- 
nations the chyle was serially diluted with 0.13 M Tris- 
HCl (pH 6.8) containing 2% (w/v) albumin, to final 
triglyceride levels of 0.023-0.9 mM. The dilution of 
the synthetic substrate for the Km determinations has 
been described [4]. 
(ii) Whether the releasable and non-releasable frac- 
tions display differences in Km-values of the 
natural triglyceride substrate. 
3. Results and discussion 
* To whom correspondence should be addressed 
Triglyceride present in chylomicrons was found to 
be a better substrate for both releasable and non- 
releasable LPL fractions, when compared to the syn- 
thetic emulsion (table 1). A Lineweaver-Burk double 
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Table 1 









Releasable 0.05 0.44 8.8 
Non-releasable 0.26 4.35 16.7 
Values shown are the mean of 2 individual experiments 
reciprocal plot of the 2 lipase activities against the 
natural substrate clearly shows that the non-releasable 
fraction has a higher Km-value than the releasable 
enzyme (fig.1). As reported in [4], and as confirmed 
here (table l), this difference in the Km-values was 
observed also with the synthetic substrate. 
We have suggested [4] that the non-releasable LPL 
represents the precursor for the endothelial-bound 
(releasable) lipase in the heart. This precursor might 
have a different conformation than the releasable 
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Fig.1. Lineweaver-Burk double reciprocal plot of releasable 
and non-releasable LPL activity with natural substrate. Releas- 
able (o-o) and non-releasable (o-o) lipase fractions 
were eluted from heparin-Sepharose columns and assayed 
with varying concentrations of chyle, as in section 2. Each 
point is the mean of duplicate analyses. Similar Lineweaver- 
Burk plots employing the synthetic substrate have been 
shown in [4]. 
enzyme, hindering access of the substrate to the 
active site. This possible inaccessibility could be even 
more pronounced when synthetic substrate is used, 
hence the increased Km ratio of synthetic/natural 
substrate in the non-releasable fraction (table 1). 
Release of the membrane-supported LPL by hepa- 
rin in heart perfusion did not change its kinetic prop- 
erties [ 13 1. The heparin-releasable fraction here was 
purified by heparin-Sepharose chromatography and 
displayed a Km-value similar to that in [ 131 (0.05 mM 
vs 0.07 mM). Thus, purification of the heparin-releas- 
able enzyme did not alter its Km-value. 
It is of interest to compare our data with reported 
Km studies of the heparin-releasable and non-releas- 
able fractions of LPL. In adipose tissue, no significant 
difference was found in Km-values between the hepa- 
rin-releasable fraction and the LPL from acetone 
powder extracts [ 141. In other studies of adipose tis- 
sue [ 151, Km of 0.23 mM for the heparin-releasable 
fraction was reported. This value is very close to that 
reported here for the non-releasable LPL in heart tis- 
sue (0.26 mM). Based on these kinetic similarities, it 
is possible that heart non-releasable LPL and the adi- 
pose LPL (releasable and non-releasable) are identical 
enzymes. The strikingly lower Km-value of the heart 
releasable enzyme mqy reflect a unique activation 
process which occurs in heart. This activation could 
occur prior to, or during the transportation of the 
LPL from its cellular location to the endothelial site. 
The activation process, resulting in the high affinity 
for the circulating substrate, could, as suggested 
[ 15 ,161, assure adequate triglyceride uptake by the 
heart even at very low substrate concentrations. 
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